Osteopenia Clinical Trials 2023

Osteopenia Clinical Trials 2023

Osteopenia research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in osteopenia clinical trials today.

Osteopenia Clinical Trials

Here are the 6 most popular medical studies for osteopenia

College Station, Texas

Protein Supplement

Whey +2 More for Mild Cognitive Impairment

Recruiting1 award6 criteria
College Station, Texas

Aging modifies the metabolic pathway of the neurotransmitter serotonin by reducing the synthesis rate and increasing the breakdown rate of serotonin, possibly related to the observed enhanced sensitivity of the serotonergic pathway. Since serotonin plays a prominent role in neuropsychological functions such as anxiety, mood and memory, the enhanced sensitivity of the serotonergic pathway in aging can probably explain the fact that elderly are more vulnerable to develop cognitive deficits and depressive symptoms. Serotonin synthesis in brain is regulated by its precursor tryptophan (TRP). Because tryptophan is an essential amino acid, modifying the availability of tryptophan through dietary intake, can directly influence central serotonin metabolism and consequently affective and cognitive processes. The aim of this study is to test the hypothesis that an acute intake of whey protein with high levels of TRP such as alpha-lactalbumin can stabilize the metabolism of serotonin and subsequently enhance metabolic and cognitive functions in healthy older adults. The acute effects of this dietary protein will be investigated in subjects with mild cognitive impairment (MCI), or dementia, compared to control subjects in order to examine whether healthy older subject with MCI benefit more from the intake of alpha-lactalbumin and/or whey. The investigators will investigate if this meal can optimize serotonin metabolism by elevating plasma TRP levels and plasma TRP appearance and enhance splanchnic TRP extraction. In addition, the effects on mood and cognitive functions will be examined.

Popular filter options for osteopenia trials

Metabolic Syndrome Clinical Trials

View 47 Metabolic Syndrome medical studies.

MetS Clinical Trials

View 27 MetS medical studies.

Osteopenia Clinical Trials With No Placebo

View 94 osteopenia medical studies that do not have a placebo group.

View More Osteopenia Trials

See another 72 medical studies focused on osteopenia.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to osteopenia

What are the top hospitals conducting osteopenia research?

When it comes to clinical trials focused on osteopenia, a condition characterized by low bone mass and an increased risk of fractures, several hospitals are leading the way. In Saint Louis, Washington University School of Medicine is currently conducting four active trials for osteopenia. Although they don't have any past trials specifically dedicated to this condition, their commitment to ongoing research highlights their dedication in understanding and treating osteopenia. Meanwhile, the University of Alabama at Birmingham has three active trials and two previously conducted studies on record since 2012, demonstrating their investment in finding innovative approaches for managing this condition.

Notably, the prestigious Mayo Clinic located in Rochester recently initiated its first osteopenia trial in 2020 but already has two ongoing trials highlighting their eagerness to contribute new insights into this field. Similarly committed to advancing our understanding of osteopenia is the University of Missouri-Columbia with two active clinical trials; however, they haven't conducted any previous investigations on this particular topic.

It's also worth mentioning that the National Institutes of Health Clinical Center situated in Bethesda holds an impressive track record with four completed studies focused on osteopenia since recording its first trial back in 2004. Currently engaged in two active clinical trials for this condition as well, their expertise positions them as a valuable resource for individuals seeking cutting-edge advancements regarding osteopenia management.

These hospitals collectively represent medical centers at various stages along the journey towards unlocking new knowledge about osteopenia prevention and treatment options. Their endeavors underscore how each research study contributes significantly to our ever-growing understanding of this complex disease—a stepping stone toward improving lives affected by weak bones and fractures.

Which are the best cities for osteopenia clinical trials?

For individuals seeking clinical trials related to osteopenia, several cities have emerged as notable hubs for research and development. Toronto in Ontario stands out with 10 ongoing trials exploring treatments like Metformin, Healthy Volunteers, and Chemoradiotherapy with Integrated Boost Dose. Atlanta in Georgia follows closely behind with 6 active studies focusing on interventions such as Dulaglutide Injection and Magnetic Resonance Spectroscopic Imaging. Additionally, Birmingham in Alabama and New york City both offer promising opportunities for participation in osteopenia clinical trials, each hosting 5 ongoing studies that investigate various treatments ranging from PET imaging to virtual reality exergaming. Lastly, New Brunswick in New jersey completes this list of top cities for osteopenia clinical trials with its own set of diverse studies examining factors like metabolic activity of HR+/Her2- breast cancer and tailored lighting intervention. These cities provide valuable access to cutting-edge research efforts aimed at uncovering innovative approaches towards managing osteopenia and improving patient outcomes.

Which are the top treatments for osteopenia being explored in clinical trials?

In the realm of osteopenia, clinical trials are exploring various treatments to combat this condition. One treatment at the forefront is exercise, which shows promising results in two active trials dedicated to osteopenia. Since its first listing in 2001, exercise has been subject to two all-time clinical trials focused on this bone health issue. These studies shed light on the potential benefits that physical activity can bring for individuals with osteopenia, offering a non-pharmacological approach worth considering.

What are the most recent clinical trials for osteopenia?

Exciting developments in osteopenia research have brought forth several recent clinical trials that hold promise for improved treatment options. One such trial explores the potential benefits of a fasting mimicking diet, aiming to determine its efficacy in managing osteopenia. Another study focuses on an intensive lifestyle intervention combined with tirzepatide, seeking to assess their combined impact on this condition. Additionally, vericiguat is being investigated for its potential role in treating osteopenia, while virtual reality exergaming and decitabine are also being explored as novel interventions. These ongoing trials offer hope for advancing our understanding and management of osteopenia moving forward.

What osteopenia clinical trials were recently completed?

Recently completed clinical trials have shed light on innovative approaches in the realm of osteopenia treatment. In December 2019, Roswell Park Cancer Institute concluded a trial investigating the efficacy of Denosumab in addressing this condition. Another notable study, sponsored by Masonic Cancer Center at the University of Minnesota, explored the use of Calcium and vitamin d and was completed in February 2015. These trials hold promise for advancing our understanding and management of osteopenia, providing potential avenues for improved care for individuals affected by this bone disorder.